BioCentury
ARTICLE | Company News

Ziarco, Pfizer deal

November 12, 2012 8:00 AM UTC

Newco Ziarco received exclusive, worldwide rights to develop and commercialize a portfolio of four assets from Pfizer for inflammatory and allergic diseases. Pfizer will receive an undisclosed equity ...